Harnessing ctDNA measurements for response assessment in metastatic castration resistant prostate cancer

FHS
July 18, 2024
12:28 pm

A new editorial paper was published in Oncotarget’s Volume 15 on July 2, 2024, entitled, “Using early on-treatment circulating tumor DNA measurements as response assessment in metastatic castration resistant prostate cancer.”

CDC recommends updated Covid vaccines for everyone 6 months and older

A panel of advisers to the Centers for Disease Control and Prevention voted 13-1 Tuesday to recommend updated Covid-19 booster shots for all Americans 6

September 12, 2023

Roche’s dual GLP-1/GIP results show promising weight loss, but also high rates of vomiting

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

September 11, 2024

Study examines oral hygiene self-care behavior among patients with mental health disorders

A study aiming to examine oral hygiene self-care behavior among patients with self-reported mental health disorders was presented at the 102nd General Session of the

March 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.